Response to third rubella vaccine dose

Human Vaccines & Immunotherapeutics
Lotta SiiraSusanne G Dudman

Abstract

Limited data exist on the immunogenicity of a third dose of the measles, mumps, and rubella vaccine (MMR). In this study, our aim was to evaluate the long-term rubella immunogenicity afforded by two childhood MMR doses of the Norwegian vaccination program in a cohort of conscripts and to determine the effect of an additional dose of MMR vaccine, in order to inform vaccination policy. Blood samples from Norwegian conscripts (n = 495) taken both before and eight months after administration of a dose of MMR vaccine were tested using an enzyme immunoassay to measure anti-rubella IgG. Concentrations <5 IU/mL were regarded as negative, 5.0-9.9 IU/mL as equivocal, and ≥10 IU/mL as positive. Overall, the seropositivity before vaccination was 84.6%, and 99.0% of the conscripts had anti-rubella IgG concentrations ≥5 IU/mL. The seropositivity after vaccination was 94.5%, and 99.8% of the conscripts had antibody concentrations ≥5 IU/mL. The geometrical mean IgG concentrations increased from 21.4 IU/mL before vaccination to 28.9 IU/mL after. Four out of five conscripts, with seronegative concentrations before administrations of an additional MMR dose, had equivocal or seropositive results following vaccination. The cohort of young adults in...Continue Reading

References

Aug 1, 1996·American Journal of Clinical Pathology·L P Skendzel
Jan 1, 1997·Scandinavian Journal of Infectious Diseases·L B FlugsrudB P Berdal
Jan 13, 2004·Clinical and Diagnostic Laboratory Immunology·Manuel Rosa-FraileEster Manrique
May 12, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Neelam DhimanGregory A Poland
Feb 3, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K VainioI Aaberge
Mar 9, 2007·Clinical and Vaccine Immunology : CVI·C Vauloup-Fellous, L Grangeot-Keros
Feb 23, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K VainioI S Aaberge
Feb 26, 2008·Bulletin of the World Health Organization·Anthony NardoneElizabeth Miller
Apr 19, 2008·The Journal of Infectious Diseases·Irja DavidkinHeikki Peltola
Jun 26, 2013·Human Vaccines & Immunotherapeutics·Alba González-EscaladaRuth Gil-Prieto
Dec 24, 2014·Vaccine·Florence Y LaiCarmen L Charlton
Jan 13, 2015·Transactions of the Royal Society of Tropical Medicine and Hygiene·Sabra L KleinEleanor N Fish
May 6, 2016·Journal of Clinical Microbiology·Elise BouthryChristelle Vauloup-Fellous
Jun 25, 2016·Vaccine·Wayne Dimech, Mick N Mulders
Mar 9, 2017·BMC Infectious Diseases·Maria Serena GalloneSilvio Tafuri
May 11, 2017·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Maria Hagerup-JenssenØystein Rolandsen Riise
Jan 9, 2018·Vaccine·W A OrensteinA Reingold

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay

Software Mentioned

STATA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.